Électricite de Strasbourg Société Anonyme (ELEC)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 155.20 |
|---|---|
| 52-week range | 152.60 – 236.99 |
| Return, 1 month / 3 months | −3.8% / −23.2% |
| Return, 1 year / 3 years | −2.3% / +103.2% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 31.5% |
| Worst drawdown (1 year) | -34.7% |
| Average daily value traded | 0.37M EUR |
| Dividend yield | 8.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Électricité de Strasbourg is a French energy company based in Strasbourg that distributes electricity across its regional network and supplies electricity and gas to households, businesses and local authorities. It operates the regulated distribution grid in its home region and also provides energy services and advice to its customers. The company is part of the EDF group, which holds a majority stake, and its activities centre on the Alsace area of eastern France.
The shares are listed on the Euronext Paris in France under the code ELEC, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Électricite de Strasbourg Société Anonyme (ELEC) trades on the Euronext Paris in France. It last closed at EUR 155.20 on 19 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 347 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it fell 23.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.1% | ||
| From 52-week high | -34.0% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.2% | ||
| 6-month return | -26.2% | ||
| 12-month return, skipping the last month | 1.6% | ||
| Risk (lower is better) | 59 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 31.5% | ||
| Worst drawdown (1 year) | -34.7% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 0.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | −3.8% |
| 3 months | −23.2% |
| 6 months | −26.2% |
| 1 year | −2.3% |
| 3 years | +103.2% |
| 5 years | +82.0% |
Signals
| 50-day / 200-day average | 161.74 / 194.32 |
|---|---|
| Golden / death cross (60 days) | Death, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jun 2026 | EUR 13.7000 |
| 30 May 2025 | EUR 11.0000 |
| 28 Jun 2024 | EUR 8.6000 |
| 30 May 2023 | EUR 2.6500 |
| 30 May 2022 | EUR 5.8000 |
| 28 May 2021 | EUR 4.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.